LEADER 03910nam  2200625 a 450 
001 9910781957003321
005 20230725053535.0
010   $a0-309-21271-5
010   $a1-283-31188-7
010   $a9786613311887
010   $a0-309-21269-3
035   $a(CKB)2550000000058086
035   $a(EBL)3378891
035   $a(SSID)ssj0000537821
035   $a(PQKBManifestationID)11334263
035   $a(PQKBTitleCode)TC0000537821
035   $a(PQKBWorkID)10554521
035   $a(PQKB)10604420
035   $a(MiAaPQ)EBC3378891
035   $a(Au-PeEL)EBL3378891
035   $a(CaPaEBR)ebr10506514
035   $a(CaONFJC)MIL331188
035   $a(OCoLC)923284604
035   $a(EXLCZ)992550000000058086
100   $a20111205d2011      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aImplementing a national cancer clinical trials system for the 21st century$b[electronic resource] $eworkshop summary /$fan American Society of Clinical Oncology and Institute of Medicine Workshop ; Alison Mack and Sharyl J. Nass, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies
210   $aWashington, D.C. $cNational Academies Press$d2011
215   $a1 online resource (100 p.)
300   $aDescription based upon print version of record.
311   $a0-309-21268-5 
320   $aIncludes bibliographical references.
327   $a""Front matter""; ""Reviewers""; ""Contents""; ""Implementing a National Cancer Clinical Trials System for the 21st Century""; ""References""; ""Acronyms""; ""A   Workshop Agenda""; ""B   Executive Summary of A National Cancer Clinical Trials System for the 21st Century""
330   $a"Clinical trials enable scientific discoveries to advance patient care, in addition to informing and guiding subsequent research. The National Cancer Institute's (NCI's) Clinical Trials Cooperative Group Program works to advance patient care and research. The Cooperative Group Program has been instrumental in establishing the standards for cancer patient care and clinical research methods. Despite broad participation in the program, financial strain and procedural burdens limit the ability of the Cooperative Group Program to undertake medical practice-changing clinical research. Thus, the Institute of Medicine's (IOM's) National Cancer Policy Forum and the American Society of Clinical Oncology held a workshop on March 21, 2011 to follow up on the 2010 IOM report, A National Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program, which made recommendations to strengthen the NCI Cooperative Group Program. In keeping with the established commitment to excellence Implementing a National Cancer Clinical Trials System for the 21st Century outlines how to improve the current system by incorporating innovative science and trial design into cancer clinical trials. It also examines the impact of increasing quality in regards to speed, efficiency, design, launch, and conduct, as well as improving prioritization, and incentivized participation."--Publisher's description.
606   $aCancer$xTreatment$xResearch$vCongresses
606   $aClinical trials$vCongresses
615  0$aCancer$xTreatment$xResearch
615  0$aClinical trials
676   $a616.994060724
701   $aMack$b Alison$01085987
701   $aNass$b Sharyl J$0857626
712 02$aNational Cancer Policy Forum (U.S.)
712 02$aInstitute of Medicine (U.S.)
712 12$aAmerican Society of Clinical Oncology and Institute of Medicine Workshop
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910781957003321
996   $aImplementing a national cancer clinical trials system for the 21st century$93684174
997   $aUNINA